Napa Valley Travel Guide

Trigemina Conducting Phase IIa Clinical Trial in Chronic Daily Headache

MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–Trigemina, Inc. (TI), a Mountain View based startup, has begun a Phase IIa clinical trial for its lead molecule in Chronic Daily Headache (CDH) in collaboration with Dr

Read the original post:
Trigemina Conducting Phase IIa Clinical Trial in Chronic Daily Headache

Comments

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!